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Abstract 
Aim 
We used register-based data to estimate the effect of all-type dementia on road traffic 
accidents (RTAs) risk, combined with comorbidities or sedative medicines, among non-
institutionalized older people in Denmark. 
Methodology 
The source population was all residents in Denmark aged 65 years and older, alive as of 
January 1, 2008 (n=853,228). Cases were those who had any type of RTA in 2009-2014. Each 
case was matched for age, sex and geographic location to four to six controls. All-type 
dementia was ascertained using ICD-10 diagnosis supplemented with prescribed medicine 
records. Eight chronic diseases were selected to assess comorbidities. Four types of medicines 
were categorized as sedative medicines for analysis. Conditional logistic regression with 
adjustment for education and marital status as well as either the number of comorbidities or 
sedative medication use was performed using STATA software. 
Results 
Older people with dementia had lower RTAs risk compared to their controls [OR=0.43, 
95%CI (0.32-0.60), p<0.001]. Significant interaction was observed between dementia and the 
number of comorbidities for RTAs estimation.  
Conclusions 
The significantly lower RTAs risk for older individuals with dementia observed in our study 
may be due to people with dementia living at home having a lower frequency of outdoor 
activities, i.e., less exposure to traffic. However, this together with interaction between 
dementia and comorbidities as well as sedative medications should be investigated further. 
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Introduction 
Worldwide, about 1.25 million people die and about 20-50 million more are injured each year 
due to road traffic accidents (RTAs) [1]. Although young people constitute the vast majority 
of RTAs, older people are more affected by injuries that result in higher fatality rates and 
higher healthcare usage [2]. As the population ages, older people comprise a greater 
proportion of road users, for example, as drivers of cars and bicycles, and as pedestrians, 
which raises public health and safety concerns. 
Many factors may contribute to cause RTAs in older people. Age in itself is an important 
factor, but other factors, such as environmental conditions and chronic diseases, also 
contribute [3]. An example of the latter is dementia, a neurodegenerative chronic disease 
which impairs neural functions involved in memory, perception, attention, vision, balance, 
speed and problem solving, impairments which are important risk factors related to RTAs [4]. 
As there will be a projected 135 million people suffering from dementia globally by 2050, 
identifying their risk for RTAs therefore has important implications for health policy and 
society at large [5].  
However, the risk of RTAs for people with dementia remains unclear. Some studies have used 
driving simulators or caregiver reports and demonstrated that patients with mild dementia, 
specifically mild Alzheimer’s disease (AD), may still be capable of driving safely [6]. Other 
studies used register reports: one concluded that drivers with dementia may have a higher risk 
of crashes [7], but two others did not find any significant association [8, 9]. While people with 
dementia reported (or their caregivers reported) that they still had the capacity to drive, a 
relatively small proportion of them are on the road [10], and we have not yet identified studies 
of the risk of RTAs for general road users with dementia. 
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Comorbidities and use of multiple medications are common among older people with 
dementia [11, 12]. Various chronic diseases have been identified as risk factors for the 
development and deterioration of dementia and for accidents [13-15]. Multiple medications, 
especially sedatives such as antipsychotics, are also related to both dementia and accidents, 
given that use of such medicines can impair cognition, motor function, and vision [16, 17]. 
Clearly, dementia concurrent with comorbidities or sedative medications may indicate excess 
risk for RTAs among the elderly. However, to date, those issues have not been well studied on 
a national level. 
Aim of the study 
Using register-based data, this study aimed to identify the RTAs risk for all types of road 
users due to all-type dementia, combined with comorbidities or sedative medicines, among the 
non-institutionalized older Danish population.  
Methods 
Data source 
The data for this population-based nested case-control study were extracted from several 
Danish national registers. Using the unique Civil Registration System (CPR) number assigned 
to each individual at birth, or to persons who hold a Danish residence permit upon 
immigration, all national registers can be linked at an individual level. A description of each 
register used in this study is detailed elsewhere [18]. In brief: 
1. The Danish Civil Registration System (CPR) records name, sex, date of birth, home 
address, marital status and other basic information for all residents of Denmark since 
1968. 
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2. The Danish National Patient Registry (DNPR) contains primary and secondary 
diagnoses, and inpatient, outpatient, and emergency department contacts of all Danish 
residents registered from 1995 onward. The International Classification of Diseases 
version 10 (ICD-10) codes were used in Denmark for disease diagnosis identification 
records beginning January 1, 1994. 
3. The Danish Psychiatric Central Research Register (PCRR) contains inpatient and 
outpatient psychiatric contacts since 1995. 
4. The Danish National Prescription Registry (LMDB) contains nationwide individual-
level data on all prescription drugs retrieved from Danish community pharmacies and 
nursing homes from 1995 onward. The date of dispensing and the dose of the 
prescribed drugs are recorded in the register using the corresponding Anatomical 
Therapeutic Chemical (ATC) codes. All drugs are assigned a defined daily dose 
(DDD) by the World Health Organization (WHO) representing the assumed average 
maintenance dose per day for a drug used for its main indication in adults. 
5. The Population Education Register (PER) includes all individuals receiving education 
in Denmark, including people who have immigrated to Denmark, and contains 
information on individuals’ highest completed education.  
6. The Nursing Home Register (AEPI) contains a yearly indicator, gauged by Statistics 
Denmark (DST) from peripheral data, of whether a person is a resident of a nursing 
home. 
Study design and population  
The source population of this study was all residents in Denmark aged 65 years and older, 
alive as of January 1, 2008 (n=853,228) using data from the CPR. 
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Cases 
Cases were defined as individuals in the source population who experienced an RTA (any 
type) between January 1, 2009 and December 31, 2014 (2009-2014) registered in the DNPR 
with any diagnosis representing a road traffic accident-related injury (ICD-10 codes: DV00-
DV89, DV98-DV99). The first date of accident registered in this period was defined as the 
index date. 
Cases were excluded from the study if they: (1) had an RTA between January 1, 2008 and 
December 31, 2008, (2) resided in a nursing home when the RTA occurred, or (3) were 
drivers recorded as driving under the influence of alcohol. Furthermore, any second RTA 
occurring after the first RTA for a case was not included as a second case in the study.  
Controls 
For each case, four to six controls matched on age, sex and geographic location were selected 
from the source population by risk-set matching, i.e. any subject is eligible for sampling as a 
control up until they become a case, and subjects can be sampled as controls for more than 
one case. Controls were those without an RTA before the case’s index date and also not living 
in a nursing home.  
The geographic location of an individual was categorized as one of three groups: large city 
(Copenhagen and Frederiksberg), medium-sized city (Aarhus, Odense, Aalborg, Esbjerg, 
Randers, and Kolding), and small cities/rural areas (all other locations except large and 
medium size cities). 
Dementia assessment 
An individual was identified with dementia if they met at least one of the following criteria: 
(1) a dementia diagnosis as the primary or secondary diagnosis in the DNPR or the PCRR 
(ICD-10 codes: F00.0, F00.1, F00.2, F00.9, G30.0, G30.1, G30.8, G30.9, F01.0, F01.1, F01.2, 
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F01.3, F01.8, F01.9, F02.0, G31.83, F02.08, F03.9), and/or (2) at least one anti-dementia drug 
registration in the LMDB (ATC: N06DA01, N06DA02, N06DA03, N06DA04, N06DX01).  
Subjects lacking a dementia registration in the DNPR but with a redeemed prescription of an 
anti-dementia drug in the LMDB were also defined as dementia patients.  
To ensure that dementia (exposure) occurred before the date of RTA (outcome), the date of 
dementia diagnosis or the first redeemed prescription of an anti-dementia drug in the registers 
had to be before the subject’s index date of RTA. 
Comorbidity assessment 
Comorbidity was assessed by the presence of one or more of eight chronic diseases including 
type 2 diabetes (T2D) (ICD-10 code: E11), chronic obstructive pulmonary disease (COPD) 
(ICD-10 codes: J40-J44), ischemic heart disease (IHD) (ICD-10 codes: I20–I25), depression 
(ICD-10 codes: F32-F33), hypertension (ID-10 codes: I10, I15), stroke (ICD-10 codes: I60-
I69), atrial fibrillation (AF) (ICD-10 code: I48), and asthma (ICD-10 code: J45), which are all 
common among the elderly Danish population [19]. This was aggregated into four categories: 
0, 1, 2, or 3 or more (3+) comorbidities. 
The identification of chronic diseases was performed similar to the identification of dementia 
as described as above and in greater detail elsewhere [18].  
Sedative medicine 
Sedative medicine was defined as the intake of any of four types of medicines: sleeping 
medicine (ATC: N05C), antipsychotic medicine (ATC: N05A), anti-anxiety medicine (ATC: 
N05B), and antidepressants (ATC: N06A). For the main analysis, we grouped these 
medications into three categories: 0, 1, or 2 or more (2+) of any combination of these four 
types of sedative medicines. 
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Because sedative medicine has a short half-life, the treatment duration of any of these 
medicines had to cover the time period 72 hours before the RTA index time for a person to be 
considered to be on this medicine at the time of the RTA.  
We used three indicators registered in the LMDB for this 72-hour interval calculation: the 
DDD, the number of packages including the number of pills per package, and the date of 
redemption. One DDD was assumed as one treatment day (24 hours). We chose the 72-hour 
interval (half-life ranged from 0-72 hours) in order to cover long-acting benzodiazepines  
Other covariates 
Education levels were grouped in the following categories according to the highest education 
level in years from the PER: low education (<10 years), medium education (10-12 years), and 
higher education (>12 years). From the CPR records, marital status was also assessed and 
grouped into four categories: married (including partnership or cohabitation), divorced 
(including dissolved partnership), widowed (including partner deceased), and unmarried. 
Statistical analyses 
The frequency (%) and/or median (range) of socio-demographic characteristics, pre-existing 
chronic diseases and medications of the groups of cases and controls were summarized as of 
January 1, 2009. Since a number of controls (n=29) also became cases, we also summarized 
the total samples. 
Using conditional (fixed effects) logistic regression conditioned on the risk sets, odds ratios 
(ORs) with corresponding 95% confidence intervals (95% CIs) were calculated as the 
measure of risk of RTAs related to dementia with adjustment for education, marital status, and 
the number of comorbidities or sedative medicines. All variables used for the main analysis 
were assessed on the index date of RTA. We tested for interaction between dementia and 
comorbidities as well as dementia and sedative medicines.  
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All statistical tests were two-sided and used a significance level of 5%. STATA 14 (Stata 
Corporation, College Station, TX, USA) was used for all statistical analysis. 
Ethical consideration  
The Danish Data Protection Agency granted permission for the study data and reviewed 
ethical considerations (J.no. 2016-41-4674). 
Results 
The characteristics of cases and controls 
Table 1 shows the characteristics of 3,211 cases and 12,527 matched controls on January 1, 
2009. In general, individuals who were divorced, widowed or never married represented 
higher numbers within the case population (12.2%, 24.8%, 5.6%, resp.) than controls (10.3, 
22.6, 5.0%, resp.), and there were more individuals with higher education in cases than 
controls (19.3% vs 17.2%, resp.).  
The median number of comorbidities was similar in cases and controls, but slightly more 
controls had 2 (59.0%) or 3+ chronic diseases (16.2%). There were also more individuals with 
2 or 3+ sedative medicines in controls (1.7% and 6.3%, resp.) than in cases (1.2% and 5.1% 
resp.).  
On January 1, 2009, a total of 0.6% of cases had dementia, while 1.2% of controls had 
dementia. Of other chronic diseases, both cases and controls had distributions similar to the 
total sample. More controls had hypertension (65.3%) than cases (63.2%), but more cases had 
IHD (69.0%) than controls (65.3%).   
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Dementia and RTAs 
On the index date, 43 and 378 individuals had dementia in the case and control populations, 
respectively. Compared to people without dementia, individuals with dementia had a 57% 
lower risk of RTA [OR=0.43, 95%CI (0.32-0.60), p<0.001] adjusted for education, marital 
status and comorbidities (Table 2). 
A significant interaction between dementia and the number of comorbidities was observed 
(interaction p=0.0032). We further analysed the interaction effect and found a lower RTA risk 
with zero comorbidity (OR=0.38), and a large increased RTA risk with one comorbidity 
(OR=1.48); however, with two or more (2+) comorbidities, the effect vanished (OR=0.96).  
By adjusting for the sedative medications instead of the comorbidity, the RTAs risk for 
dementia remained the same [OR=0.43, 95%CI (0.31-0.59), p<0.001] (Table 3). However, 
older people who had taken one or more sedative medicines had a higher RTA risk as 
compared to those who had not taken such medicines. No significant interaction was observed 
between dementia and the use of the sedative medicines for the effect of RTAs (p>0.05). 
Discussion 
Using register data, this study assessed non-institutionalized Danish older people and found a 
57% lower RTA risk in people with dementia compared to their matched controls. This 
finding was contradictory to what we had hypothesized [18]. However, our result cannot be 
interpreted as indicative of a protective effect for RTAs, and may instead relate to lower rates 
of daily outdoor activity among the population of dementia patients living at home. 
Epidemiology studies measuring the exact frequency of daily outdoor activities for home-
dwelling patients with dementia are sparse. A Danish study using a caregiver questionnaire 
reported that among patients living at home with mild AD, fewer than 40% visited others or 
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had social activities outside their home more than once per week, and nearly 30% never left 
their home for social activities [20].  
Another study used semi-structured interviews with 22 people with early to moderate 
dementia and their caregivers and also reported that dementia impacts the frequency of 
outdoor activity, and limits both the time (to less than one hour) and the areas visited to those 
that were most familiar, for instance, supermarkets [21].  
Furthermore, a study using an infrared sensor to measure the outdoor activity of people with 
dementia over a period of one year indicated a significantly lower number of outings 
compared to the control group of people without dementia (8.8 vs. 17.3, p<0.01) [22].  
Although dementia is associated with impaired cognitive functions, communication deficits, 
and other emotional and behavioural changes which may influence social relations, 
caregivers’ emotional reactions and the stress of safely caring for such patients may also be a 
reason for limiting the frequency of outdoor activities of patients [23]. A study has also 
suggested that people with dementia may voluntarily restrict their mobility under some 
circumstances, as possibly due to the nature of the disease they may lose interest in previously 
enjoyable activities; hence, withdrawal from such activities may even be a symptom or 
precursor of dementia [24]. In addition, sufficient social supports may also have an effect on 
RTAs risk in Denmark. An example is the home visits by health professionals provided to 
patients at no cost, which may result in decreased exposure to traffic between home and health 
clinics or hospitals.  
Research on RTAs risk for older people with dementia on a national level has rarely been 
conducted. In a study among older Australian citizens [25], Meuleners and Hobday observed 
that older people with dementia experienced fewer transport-related injuries (2.6%) than those 
without dementia (5.6%), which is in accordance with our study. However, the Australian 
study did not analyse the injury risk by dementia alone, as in our study. 
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In addition to the studies discussed above, the majority of other studies have investigated the 
risk of being a driver with dementia and the risk for RTAs. A systematic review of 23 studies 
revealed that although drivers with dementia were poor performers in driving skills that were 
either tested or reported, they did not actually result in higher crash rates [26]. Notably, many 
of the studies included in this review used either driving stimulators or caregiver reports for 
measuring crashes; register-based crash report data has seldom been studied. We used real-life 
RTA cases that were registered in the hospital emergency room system, a method which 
allowed us to include older people not only as drivers but also as pedestrians, passengers, and 
other road users in Denmark from 2009-2014. 
In terms of comorbidity, we found significant interaction between dementia and comorbidities 
for effect on RTAs. Comparing people with zero and one comorbidity, the interaction effect 
was significantly different: a lower RTA risk with zero comorbidity (OR=0.38) and a large 
increase for RTA risk with one comorbidity (OR=1.48); and then, as mentioned above, this 
interaction effect vanished for those with two or more (2+) comorbidities (OR=0.96). Using 
our dataset, we were unable to explain this finding, as we had expected that an increase in the 
number of comorbidities would result in an even lower risk of RTAs due to greater 
restrictions on mobility for those with several comorbidities and hence a lower chance of 
RTA. However, it is possible that individuals with one chronic disease may need to visit 
general practitioners and hospitals more frequently and this may increase the risk of RTAs. By 
contrast, people with multiple chronic diseases may require caregivers to coordinate or 
conduct a multitude of such activities outside of the home, and caregivers presumably 
function to lower the risk of RTAs. Since the design and variables examined in this study 
cannot provide a meaningful explanation of this observed phenomenon, further studies should 
investigate and verify this difference in interaction in order to better understand its 
significance.  
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In our cohort, over 17% of individuals had taken the selected sedative medicines on January 1, 
2009 and 6% had taken three or more. Any use of sedative medicine on the index date was a 
significant independent risk factor for traffic accidents, which is in agreement with many 
studies [27], but is also contrary to others [28].  
However, the interaction between the number of sedative medicines and dementia for RTAs 
was not significant, i.e. the effect of sedative medicine on traffic accidents was not different 
between people with and without dementia. This was also contrary to our expectation, as we 
had expected that patients with dementia would experience a stronger sedative effect than 
someone without dementia [18]. Moreover, dementia patients are potential inappropriate 
medication users, both for prescribed and over the counter medications [29]. However, using 
the register-based data, we were unable to capture the intake of over the counter medicines 
that may play a role in traffic safety, either alone or interacting with dementia or prescribed 
medications. 
This study population was people 65+ years at baseline. In Denmark, although the retirement 
age was 65 years in 2008, a certain number of older people indeed continue to work past that 
age. We found that people with higher education were represented at higher numbers in traffic 
accidents and this may be due to the fact that highly-educated people tend to stay on the job 
market longer and therefore may be exposed to traffic more frequently [10]. 
There are some limitations in our study and potential underreporting of RTAs is one of them. 
DST acknowledges that underreporting of RTAs occurs even in the population-based register, 
especially for accidents involving only slight injuries/damages and for low-impact car 
accidents without injuries. In fact, all the injuries caused by RTAs assessed in our study were 
severe enough to require medical attention or treatment, although some RTAs were registered 
as minor injuries. However, our study is not the only one affected by underreporting of RTAs, 
as one other study using state records acknowledged similar circumstances [30]. Nevertheless, 
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using case-control study design we were careful throughout the study design process to 
minimize the risk of under-detection of such very minor accidents.  
We measured RTAs as one risk category, but drivers, pedestrians, and other road users with 
dementia may present different levels of risks of RTAs, and further studies of this nuance 
should be considered. 
Another limitation may be inaccuracy in nursing home residency status that we retrieved for 
the present study. A validation study found that DST misclassified some individuals as 
nursing home residents or community dwellers [31]. However, as the proportion of nursing 
home residents was relatively small (2%, data available upon request) in our study population, 
such misclassification from DST presumably had a minor impact on our overall conclusions. 
Further studies may consider obtaining nursing home residents’ information directly from 
municipalities. 
Severity and different types of dementia may cause different magnitudes of accident risk [32-
34], and different types of dementia pathologies may overlap and be co-occurring [35]. Due to 
the low validity of subtypes of dementia and lack of severity assessment in the register data 
utilised [36], we only analysed all-type dementia in this study. Given the advancements in 
diagnostic methods that have improved diagnosis of subtypes of dementia, future studies that 
include subtypes as a category of investigation should also be considered. In the context of 
national register data, time elapsed since the first dementia diagnosis could be a good proxy 
for onset and thus severity of dementia.  
Conclusion 
Non-institutionalized older people with dementia in Denmark have a lower risk of RTAs, 
which could be due to less-frequent activities outside of the home. However, the interaction 
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between dementia and comorbidities as well as sedative medications should be investigated 
further. 
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Tables 
 
Table 1: Characteristics of cases with matched controls for age, sex, and geographic location on January 1, 2009.  
 All Case Control 
  n=15709 n=3211 n=12527a 
Socio-demographic factors    
Age (median) (range) 77.8 (6.0) (69.0-103.0) 77.8 (6.0) (69.0-97.0) 77.8 (6.1) (69.0-103.0) 
Age group, n (%)    
    65-69 14 (0.09) 3 (0.09) 11 (0.09) 
    70-74 5785 (36.83) 1174 (36.56) 4630 (36.96) 
    75-79 4291 (27.32) 871 (27.13) 3422 (27.32) 
    80-84 3352 (21.34) 685 (21.33) 2674 (21.35) 
    >=85 2267 (14.43) 478 (14.89) 1790 (14.29) 
Sex, n (%)    
    Male 8725 (55.54) 1781 (55.47) 6964 (55.59) 
    Female 6984 (44.46) 1430 (44.53) 5563 (44.41) 
Civil status, n (%)    
    Married/cohabiting 9602 (61.12) 1846 (57.49) 7778 (62.09) 
    Divorced 1675 (10.66) 391 (12.18) 1287 (10.27) 
    Widowed 3626 (23.08) 795 (24.76) 2834 (22.62) 
    Never married 806 (5.13) 179 (5.57) 628 (5.01) 
Education, n (%)    
    <10 years 7134 (44.46) 1448 (45.09) 5700 (45.50) 
    10-12 years 5144 (32.75) 1012 (31.52) 4140 (33.05) 
    >12 years 2767 (17.61) 620 (19.31) 2152 (17.18) 
Geographic location, n (%)    
    Large cities 12084 (76.92) 2468 (76.86) 9637 (76.93) 
    Medium-sized towns 2608 (16.60) 535 (16.66) 2079 (16.60) 
    Small towns/rural 1017 (6.47) 208 (6.48) 811 (6.47) 
Chronic diseases, n (%)    
    Dementia 171 (1.09) 18 (0.56) 153 (1.22) 
    Type 2 Diabetes 564 (3.59) 115 (3.58) 449 (3.58) 
    COPD 3190 (20.31) 672 (20.93) 2523 (20.14) 
    IHD 11081 (70.54) 2215 (68.98) 8885 (65.27) 
    Depression 3197 (20.35) 656 (20.43) 2544 (20.31) 
    Hypertension 10189 (64.86) 2028 (63.16) 8176 (65.27) 
    Stroke 6187 (39.39) 1257 (39.15) 4940 (39.43) 
    Atrial fibrillation 8124 (51.74) 1648 (51.32) 6488 (51.79) 
    Asthma 3293 (20.96) 694 (21.61) 2604 (20.79) 
Comorbidityb (median) (range)      2.93 (1.99) (0.00 - 9.00) 2.90 (2.02) (0.00 - 8.00) 2.93 (1.99) (0.00 - 9.00) 
Quantity of comorbidityc, n (%)    
    0 3118 (19.85) 663 (20.65) 2463 (19.66) 
    1 822 (5.23) 182 (5.67) 644 (5.14) 
    2 2533 (16.12) 510 (15.88) 2026 (16.17) 
    3+ 9236 (58.79) 1856 (57.80) 7394 (59.02) 
Medicine use, n (%)    
    Polypharmacyd 112 (0.71) 15 (0.47) 97 (0.77) 
    Sleeping medicine 811 (5.16) 162 (5.05) 652 (5.20) 
    Antipsychotic medicine 65 (0.41) 9 (0.28) 56 (0.45) 
    Anti-anxiety medicine 317 (2.02) 62 (1.93) 255 (2.04) 
    Antidepressants 1047 (6.66) 181 (5.64) 868 (6.93) 
Quantity of sedative medicinee, n (%)   
    0 12917 (82.23) 2695 (83.93) 10245 (81.78) 
    1 1588 (10.11) 312 (9.72) 1281 (10.23) 
    2  253 (1.61) 39 (1.21) 214 (1.71) 
    3+ 951 (6.05) 165 (5.14) 783 (6.28) 
a29 control individuals also became cases. 
bThe sum of the chronic diseases including type 2 diabetes (T2D), chronic obstructive pulmonary disease (COPD), ischemic 
heart disease (IHD), depression, hypertension, stroke , atrial fibrillation (AF), and asthma assessed on January 1, 2009. 
CAny combination of the chronic diseases listed in (b) assessed on January 1, 2009. 
dAny use of five or more medications by a patient on January 1, 2009. 
eAny combination of sleeping, antipsychotic, anti-anxiety, and antidepressant medicine assessed on January 1, 2009. 
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Table 2: Dementia (all-type) for the risk of road traffic accidents (RTAs) (2009-2014) adjusted for marital status, 
education, and the number of comorbiditiesa. 
  Road traffic accidents 
  OR 95% CIs p-value 
Dementia (all-type) 0.43 0.32-0.60 <0.001 
Marital status    
    Married/cohabiting ref   
    Divorced 1.30 1.15-1.47 <0.001 
    Widowed 1.21 1.09-1.34 <0.001 
    Never married 1.21 1.02-1.44 0.033 
Education    
    <10 years ref   
    10-12 years 0.98 0.89-1.07 0.668 
    >12 years 1.15 1.03-1.28 0.010 
    Not available 0.92 0.75-1.14 0.448 
Comorbidityb    
    0 ref   
    1 0.98 0.80-1.22 0.887 
    2 0.97 0.84-1.13 0.718 
    3+ 0.95 0.85-1.07 0.386 
aAll variables included in this table were based on the index date of RTA.  
bComorbidity in this analysis was calculated based on any combination of eight chronic diseases including type 2 
diabetes (T2D), chronic obstructive pulmonary disease (COPD), ischemic heart disease (IHD), depression, 
hypertension, stroke , atrial fibrillation (AF), and asthma by the index date of RTA. 
OR=Odds ratio, 95% CIs=95% confidence intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
 
Table 3: Dementia (all-type) for the risk of road traffic accidents (RTAs) (2009-2014) adjusted for marital status, 
education, and the number of sedative medicines takena. 
  Road traffic accidents 
  OR 95% CI p-value 
Dementia (all-type) 0.43 0.31-0.59 <0.001 
Marital status    
    Married/cohabiting ref   
    Divorced 1.30 1.15-1.47 <0.001 
    Widowed 1.21 1.09-1.34 <0.001 
    Never married 1.22 1.02-1.45 0.028 
Education    
    <10 years ref   
    10-12 years 0.98 0.90-1.08 0.701 
    >12 years 1.16 1.04-1.29 0.009 
    Not available 0.93 0.75-1.14 0.479 
Sedative medicineb    
    0 ref   
    1 1.17 1.04-1.30 0.006 
    2+c 1.26 1.14-1.39 <0.001 
aAll variables included in this table were based on the index date of RTA. 
bSedative medicine in this analysis was calculated based on any combination of four types of medicine including 
sleeping medicine (ATC: N05C), antipsychotic medicine (ATC: N05A), anti-anxiety medicine (ATC: N05B), and 
antidepressants (ATC: N06A) by the index date of RTA. 
cAny combination of two sedative medicines listed in (b). 
OR=Odds ratio, 95% CIs=95% confidence intervals. 
 
